Plus Therapeutics, Inc. (PSTV)

NASDAQ: PSTV · IEX Real-Time Price · USD

1.550

+0.050 (3.33%)

At close: Jul 2, 2024, 4:00 PM

1.600

+0.050 (3.23%)

After-hours: Jul 2, 2024, 5:34 PM EDT

Plus Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1998
Net Income	-13.32	-20.28	-13.4	-8.24	-11.44	Upgrade
Depreciation & Amortization	0.75	0.71	0.42	0.37	0.91	Upgrade
Share-Based Compensation	0.57	0.61	0.61	0.25	0.13	Upgrade
Other Operating Activities	-0.85	5.99	2.09	-0.81	3.95	Upgrade
Operating Cash Flow	-12.85	-12.97	-10.28	-8.43	-5.91	Upgrade
Capital Expenditures	-0.16	-0.51	-0.08	-0.09	-0.07	Upgrade
Acquisitions	0	0	0	0	5.64	Upgrade
Other Investing Activities	-	-0.25	-	-0.4	-	Upgrade
Investing Cash Flow	-0.16	-0.76	-0.08	-0.49	5.57	Upgrade
Share Issuance / Repurchase	5.4	15.83	20.69	5.11	16.45	Upgrade
Debt Issued / Paid	-1.61	-1.61	-0.28	-5.42	-3.82	Upgrade
Other Financing Activities	-0.35	-0.77	-	-	-	Upgrade
Financing Cash Flow	3.45	13.45	20.42	-0.32	12.63	Upgrade
Exchange Rate Effect	0	0	0	0	-0	Upgrade
Net Cash Flow	-9.57	-0.28	10.05	-9.25	12.29	Upgrade
Free Cash Flow	-13.01	-13.48	-10.36	-8.53	-5.97	Upgrade
Free Cash Flow Margin	-264.83%	-6018.30%	-	-2814.19%	-85.35%	Upgrade
Free Cash Flow Per Share	-4.14	-7.70	-12.85	-28.87	-64.70	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).